BiotechTube
Home/Provirex/Oliver Ahnfeld
OA

Oliver Ahnfeld

Co-Founder, Chief Financial Officer

Provirex

Therapeutic Areas

Infectious DiseaseHIVHTLV-1

Provirex Pipeline

DrugIndicationPhase
Brec1-based TherapyHIV-1 Infection (Functional Cure)Pre-clinical
Recombinase PlatformHTLV-1 InfectionResearch/Platform Development

Leadership Team at Provirex

DJ
Dr. Jan Claas-von Jachmann
Partner, Chief Executive Officer
PD
PD Dr. Jan Chemnitz MBA
Co-Founder, Chief Scientific Officer
View full Provirex profile